assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 1300.4 vs. 0.9% nacl fluid replacement in patients with severe sepsis the crystmas study血流动力学评估疗效和安全性6% hydroxyethylstarch 1300.4和0.9%氯化钠液替代crystmas严重脓毒症患者的研究.pdfVIP

  • 2
  • 0
  • 约7.44万字
  • 约 10页
  • 2017-09-05 发布于上海
  • 举报

assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 1300.4 vs. 0.9% nacl fluid replacement in patients with severe sepsis the crystmas study血流动力学评估疗效和安全性6% hydroxyethylstarch 1300.4和0.9%氯化钠液替代crystmas严重脓毒症患者的研究.pdf

assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 1300.4 vs. 0.9% nacl fluid replacement in patients with severe sepsis the crystmas study血流动力学评估疗效和安全性6% hydroxyethylstarch 1300.4和0.9%氯化钠液替代crystmas严重脓毒症患者的研究

Guidet et al. Critical Care 2012, 16:R94 /content/16/3/R94 RESEARCH Open Access Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study 1,2,3* 4 5 6,7 8 9 Bertrand Guidet , Olivier Martinet , Thierry Boulain , Francois Philippart , Jean

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档